📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial. (2025)

First Author: Harris V

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00431-6

PubMed Identifier: 39265595

Publication URI: http://europepmc.org/abstract/MED/39265595

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet. Infectious diseases

Issue: 1

ISSN: 1473-3099